Position
Chief Business Officer
Company
Georgiamune
GaithersburgBiotechnologyHealth CareMedicalTherapeuticsDescription
Georgiamune Inc. has appointed Mark Avagliano as Chief Business Officer to empower the company to meet pivotal milestones and ensure the progress of its earlier stage pipeline. With over two decades of biopharma industry experience, Avagliano brings extensive skills to lead corporate strategy, business development, and portfolio prioritization efforts.
Quick answer
Georgiamune Inc. Appoints Mark Avagliano as Chief Business Officer (November 19, 2024). Georgiamune is based in Gaithersburg, Maryland, United States.
- Who is the new Chief Business Officer at Georgiamune?
- Georgiamune named Mark Avagliano Chief Business Officer, announced November 19, 2024.
- What did Georgiamune announce on November 19, 2024?
- Georgiamune Inc. has appointed Mark Avagliano as Chief Business Officer to empower the company to meet pivotal milestones and ensure the progress of its earlier stage pipeline. With over two decades of biopharma industry experience, Avagliano brings extensive skills to lead corporate strategy, business development, and portfolio prioritization efforts.
- What does Georgiamune do?
- Georgiamune Inc. is a clinical-stage science and discovery biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.
- Where is Georgiamune based?
- Georgiamune is based in Gaithersburg, Maryland, United States.
- Which similar companies made leadership changes around the same time?
- NRx Pharmaceuticals (November 18, 2024), Diakonos Oncology (November 18, 2024), neurocare (November 21, 2024) and Faeth Therapeutics (November 22, 2024) also announced leadership changes within 45 days of Georgiamune.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer (November 18, 2024)
- neurocare Group AG Appoints Kevin Reeder as Chief Financial Officer (November 21, 2024)
- Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer (November 22, 2024)
- ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer (November 14, 2024)
- Greywolf Therapeutics Appoints Darlene Deptula-Hicks as Chief Financial Officer (November 14, 2024)
Who to call at Georgiamune, and when
A new leader at Georgiamune brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Georgiamune raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Georgiamune, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Georgiamune. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Georgiamune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Georgiamune changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.